UBS AM
ASTX

UBS AM’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

UBS AM’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-26,200
Closed -$222K – 2620
2013
Q3 		$222K Hold
26,200
– – ﹤0.01% 2284
2013
Q2 		$108K Buy
+26,200
New +$141K ﹤0.01% 2398

UBS AM's ASTX Position: Q4 2013 in Review

UBS AM sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 26,200 shares — an estimated $222K sold.

UBS AM first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $222K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • UBS AM reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • UBS AM sold 26,200 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $222K.
  • UBS AM first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • UBS AM's ASTEX PHARMACEUTICALS, INC COM position peaked at $222K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.